FAQ
Alle
- Alle
- Om Covid-19
- Om prøven
Videre lesing
- Hassan AO et al. A SARS- CoV-2 Infection model in mice demonstrates protection by neutralizing antibodies. Cell 2020 https://doi.org/10.1016/j.cell.2020.06.011
- Chandrashekar A et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science 2020 https://doi.org/10.1126/science.abc4776
- https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/
- https://airtable.com/shrSAi6t5WFwqo3GM/tblEzPQS5fnc0FHYR/viwDBH7b6FjmIBX5x?blocks=bipZFzhJ7wHPv7x9z
- Slaoui M, Hepburn M. Developing safe and effective covid vaccines — Operation Warp Speed’s strategy and approach. N Engl J Med 2020, DOI: 10.1056/NEJMp2027405
- Jackson LA et al. An mRNA vaccine against SARS-CoV-2 — preliminary report. N Engl J Med 2020, DOI: 10.1056/NEJMoa2022483
- https://www.modernatx.com/modernas-work-potential-vaccine-against-covid-19
- Gudbjartsson DF et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med 2020, 382, 2302-15
- Gudbjartsson DF et al. Humoral immune response to SARS-CoV-2 in Iceland. N Engl J Med 2020 DOI: 10.1056/NEJMoa2026116
- Alter G, Seder R. The power of antibody-based surveillance. N Engl J Med September 1, 2020 DOI: 10.1056/NEJMe2028079
26.09.2020 CA Drevon